期刊
TRENDS IN PHARMACOLOGICAL SCIENCES
卷 40, 期 4, 页码 278-293出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2019.02.003
关键词
-
资金
- US National Institutes of Health [NS085201, NS094164, NS108446, NS108312]
- National Multiple Sclerosis Society [RG-1501-02577, FG 2063-A1/2]
The family of adhesion G protein-coupled receptors (aGPCRs) consists of 33 members in humans. Although the majority are orphan receptors with unknown functions, many reports have demonstrated critical functions for some members of this family in organogenesis, neurodevelopment, myelination, angiogenesis, and cancer progression. Importantly, mutations in several aGPCRs have been linked to human diseases. The crystal structure of a shared protein domain, the GPCR Autoproteolysis INducing (GAIN) domain, has enabled the discovery of a common signaling mechanism - a tethered agonist - for this class of receptors. A series of recent reports has shed new light on their biological functions and disease relevance. This review focuses on these recent advances in our understanding of aGPCR biology in the nervous system and the untapped potential of aGPCRs as novel therapeutic targets for neurological disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据